<DOC>
	<DOCNO>NCT01596153</DOCNO>
	<brief_summary>The purpose study compare effect enhance probiotic ( EP , Live Rx ) versus placebo ( PL ) incidence Clostridium difficile associate diarrhea ( CDAD ) antibiotic associate diarrhea ( AAD ) hospitalize patient initiated antibiotic .</brief_summary>
	<brief_title>Probiotics Hospitalized Patients Study</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>18 year age older admit SSH prescribe antibiotic expect duration &gt; 3 day ( may include patient antibiotics prior admission ) . 1 . History chronic diarrhea illness ( Irritable Bowel Disease ( IBD ) , Irritable Bowel Syndrome ( IBS ) , Celiac Disease , Chronic pancreatitis 2 . Diarrhea screen 3 . Active Colitis etiology 4 . History colectomy 5 . Regular consumption probiotic within 72 hour 6 . Unable provide write consent 7 . History active pancreatitis 8 . Severe Sepsis Septic Shock ( sepsis end organ failure e.g . renal failure , ARDS , MS change meet criterion n ational guideline , require vasopressor ) 9 . Hypersensitivity ingredient probiotic product 10 . Severe Immunosuppression ( ANC &lt; 1000 , AIDS/CD4 count &lt; 200 cell , cancer active chemothereapy , h/o solid bone marrow transplant ) 12 . Acute burn injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>